Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Northwestern Start-Up Wins TechWeek Competition
Uncategorized

Northwestern Start-Up Wins TechWeek Competition

By medwebJul 6, 2012
Share
Facebook Twitter Email
BriteSeed members (from left to right) Mayank Vijayvergia, Jonathan Gunn, Paul Fehrenbacher, and Muneeb Bokhari won first place at thr 2012 TechWeek LAUNCH competition.

The medical device start-up company, BriteSeed, developed by a team of four Northwestern University graduate students, won first place at the second annual 2012 TechWeek LAUNCH competition, earning the company more than $100,000 in cash and prizes. 

At TechWeek, BriteSeed was one of five finalists out of 123 startup companies from across the country to pitch to a panel of judges.  The competition was one of the main events at the TechWeek conference held from June 22-26 at Chicago’s Merchandise Mart.

“To interact with such a diverse group of individuals and companies that share a passion for bringing life changing ideas to market was an incredible experience.  BriteSeed is honored to have represented the startup community of Chicago at such an impressive forum,” said Paul Fehrenbacher, a fourth-year medical student at Northwestern University Feinberg School of Medicine.

Fehrenbacher and the three other co-founders of BriteSeed, Mayank Vijayvergia from the McCormick School of Engineering, and Jonathan Gunn, PhD, and Muneeb Bokhari, JD, from Northwestern University Law School, started the company after inventing SafeSnips during the NUvention: Medical Innovation course.

“When we won first place at TechWeek, it was a turning point for BriteSeed.  The company is now more committed and focused than ever on bringing medical technologies to market that improve surgical outcomes for patients while at the same time saving the U.S. healthcare system money,” said Fehrenbacher. “SafeSnips is an example of such a novel device. SafeSnips is a patent-pending technology that eliminates accidental cuts into blood vessels and thereby helps all the major stakeholders in healthcare: patients, surgeons, hospitals, insurance companies, and the government.”  

While shadowing surgeons, including David Mahvi, MD, ­­chief of gastrointestinal and oncologic surgery and James R. Hines, MD, Professor of Surgery at Feinberg and an advisor to BriteSeed, the team invented the technology, SafeSnips integrates into surgical tools to alert surgeons of the presence of blood vessels prior to cutting tissue.  By doing so, SafeSnips will eliminate excessive bleeding from unintended cuts into blood vessels.

“Without Northwestern and the NUvention course, BriteSeed would not even be a figment of our imagination,” Fehrenbacher said.  “We hope that BriteSeed’s continued success serves as an inspiration for future Northwestern students to take the NUvention courses. These courses provide the initial tools needed to commercialize academically conceived ideas and make a meaningful impact in the world.”

Northwestern’s NUvention Medical Innovation course brings together students from across the University to form businesses and solve previously unaddressed clinical problems. The course is offered through the NUCATS Clinical and Translational Sciences Institute.

Fehrenbacher said that he took the NUvention: Medical Innovation course because he has had an interest in entrepreneurship from a young age.

“I have always been committed to using my medical degree for the betterment of patients.  After taking the course, I now know that I can use my medical degree and my interest in entrepreneurship to this end.” he said.

Education
Share. Facebook Twitter Email

Related Posts

Honoring the PA Class of 2022

Jun 1, 2022

Celebrating Honors Day 2022

May 23, 2022

Taking a Second Look at Feinberg

Apr 21, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.